Pharmaace
Pharmaace, a leading player in the pharmaceutical industry, is headquartered in the United States and operates across major regions globally. Founded in 2010, the company has established itself as a key provider of innovative solutions in drug development and regulatory affairs. Pharmaace offers a range of core services, including clinical trial management, regulatory consulting, and pharmacovigilance, distinguished by their commitment to quality and compliance. With a focus on enhancing the efficiency of drug development processes, Pharmaace has achieved notable milestones, including successful collaborations with various biotech firms and pharmaceutical companies. Recognised for its expertise and customer-centric approach, Pharmaace continues to strengthen its market position, making significant contributions to the advancement of healthcare solutions worldwide.
DitchCarbon Score
How does Pharmaace's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaace's score of 10 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaace's reported carbon emissions
PharmaACE, headquartered in the United States, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. Although specific emissions data for the most recent year is not available, the company has established a target to reduce its Scope 1 and Scope 2 emissions by 42% by the year 2030, using 2022 as the baseline year. This target has been validated through the Science Based Targets initiative (SBTi), ensuring alignment with the global goal of limiting temperature rise to 1.5°C. PharmaACE's commitment includes not only the reduction of direct emissions (Scope 1) and indirect emissions from energy consumption (Scope 2) but also a pledge to measure and address its Scope 3 emissions, which encompass the broader impact of its value chain. This comprehensive approach reflects the company's dedication to sustainability and responsible environmental stewardship within the professional services sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaace is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
